Osteoporosis: Trials and tribulations
- 1 August 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (2), S74-S89
- https://doi.org/10.1016/s0002-9343(97)90029-2
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?Bone, 1995
- Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapyJournal of Bone and Mineral Research, 1995
- The effects of risedronate on canine cancellous bone remodeling: Three-dimensional kinetic reconstruction of the remodeling siteJournal of Bone and Mineral Research, 1995
- Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysisJournal of Bone and Mineral Research, 1994
- Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.Journal of Clinical Investigation, 1993
- Treatment of Postmenopausal Osteoporosis with Calcitriol or CalciumNew England Journal of Medicine, 1992
- Structural and geometric changes in iliac bone: Relationship to normal aging and osteoporosisJournal of Bone and Mineral Research, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Effect of 1,25‐dihydroxy ‐ vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosisEuropean Journal of Clinical Investigation, 1981